Click image to enlarge
The V-PLEX SARS-CoV-2 Panel 13 (IgG) Kit is a multiplex serology assay for antibodies to ten Spike antigens from variants of SARS-CoV-2, including the Alpha, Beta, Gamma, Delta, and several emerging variants. Panel 13 has Spike antigens from the following lineages: A (WT), (B.1.1.7), (B.1.351), (B.1.526.1), (B.1.617), (B.1.617.1), (B.1.617.2), (B.1.617.3), (P.1), and (P.2).
-
Specifications
-
-
-
References
-
Documentation
Analyte(s)
|
|
SARS-CoV-2 Spike, SARS-CoV-2 Spike (B.1.1.7), SARS-CoV-2 Spike (B.1.351), SARS-CoV-2 Spike (B.1.526.1), SARS-CoV-2 Spike (B.1.617), SARS-CoV-2 Spike (B.1.617.1), SARS-CoV-2 Spike (B.1.617.2), SARS-CoV-2 Spike (B.1.617.3), SARS-CoV-2 Spike (P.1), SARS-CoV-2 Spike (P.2)
|
|
Species
|
|
Human
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120
|
|
Plate Type
|
|
96-well
|
|
Sample Type
|
|
Serum, Plasma, Saliva, Upper Respiratory Sample
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Title
|
Journal
|
Year
|
|
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
|
|
|
|
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
|
|
|
|
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination
|
|
|
|
Sensitive Serology Measurements in the Saliva of Individuals with COVID-19 Symptoms Using a Multiplexed Immunoassay
|
|
|
|
Quantitative serology for SARS-CoV-2 using self-collected saliva and finger-stick blood
|
|
|
|
View All
|
Product Inserts
|
|
|
Handouts
|
|
|
Certificate of analysis
|
|
View More
|
SDS
|
|
|
Meso Scale Japan 株式会社